Sheng-Li Xue (Shengli Xue)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 46

Top Venues

Blood cancer journal

Bone marrow transplantation

British journal of haematology

Annals of hematology

First Affiliated Hospital of Soochow University

Soochow University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

First Affiliated Hospital of Soochow University Aug 30 2002

China

Associate Professor

Education History

Soochow University Sep 01 2008 - Jun 30 2011

China

PHD

Huazhong University of Science and Technology Sep 01 1999 - Jun 30 2002

China

MSC

Publications

Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Peiqi Liang, Yan Xie, Ziyi Liu, Dong Wang, Qian Li, Yin Lu, Sheng-Li Xue, Ying Wang, Suning Chen, Deipei Wu, Jianhong Fu
Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia. British journal of haematology 204 (4) (2024)
Peiqi Liang, Yan Xie, Ziyi Liu, Dong Wang, Qian Li, Yin Lu, Sheng-Li Xue, Ying Wang, Suning Chen, Deipei Wu, Jianhong Fu
Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia. British journal of haematology (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Han-Yu Cao, Hui-Ying Li, Wen-Zhi Cai, Yuan-Hong Huang, Qiao-Cheng Qiu, Zheng- Li, Yang Xu, Sheng-Li Xue, Hai-Ping Dai
Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements. Annals of hematology (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation (2024)
Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification. Blood cancer journal 14 (1) (2024)
Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification. Blood cancer journal 14 (1) (2024)
Peiqi Liang, Yan Xie, Ziyi Liu, Dong Wang, Qian Li, Yin Lu, Sheng-Li Xue, Ying Wang, Suning Chen, Deipei Wu, Jianhong Fu
Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia. British journal of haematology 204 (4) (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Zhiyu Zhang, Man Qiao, Xiebing Bao, Jing Lu, Jingren Zhang, Xueqing Dou, Xuefeng He, Xiao-Jin Wu, Chengcheng Fu, Xiao-Wen Tang, Miao Miao, Yue Han, Sheng-Li Xue, Huiying Qiu, Caixia Li, Ying Wang, Zhengming Jin, De-Pei Wu, Su-Ning Chen
Influence of the Omicron outbreak on allo-HSCT recipients in China: a single-center short-term observational cohort study. Bone marrow transplantation 59 (3) (2024)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-Shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study. Blood cancer journal 13 (1) (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Yuan-Hong Huang, Chao-Ling Wan, Hai-Ping Dai, Sheng-Li Xue
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma. Annals of hematology (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Liyun Chen, Wen-Jie Gong, Ming-Hao Li, Hai-Xia Zhou, Ming-Zhu Xu, Chong-Sheng Qian, Li-Qing Kang, Nan Xu, Zhou Yu, Man Qiao, Tong-Tong Zhang, Ling Zhang, Zheng-Long Tian, Ai-Ning Sun, Lei Yu, De-Pei Wu, Sheng-Li Xue
Anti-CD19 CAR T-Cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia. Blood advances (2023)
Kai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, Man Wang, Hong-Jie Shen, Si-Man Huang, Han-Yu Cao, Chao-Ling Wan, Yan-Yan Li, Hai-Ping Dai, Sheng-Li Xue
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review. Annals of hematology (2023)
Jundan Xie, Xiebing Bao, Sheng-Li Xue, Hongjie Shen, Jiannong Cen, Li Yao, Jinlan Pan, MIngqing Zhu, Dandan Liu, Xiaohui Hu, Qian Wu, Jingren Zhang, Haiping Dai, Yanglin Cao, Xuefeng He, Xiaowen Tang, Ai-Ning Sun, Ying Wang, Jianhong Fu, Huiying Qiu, Xiaofei Yang, Su-Ning Chen, De-Pei Wu
Venetoclax with Decitabine as Frontline Treatment for Younger Adults with Newly Diagnosed ELN Adverse-Risk AML. Blood (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal 13 (1) (2023)
Keyuan Zhang, Xiang Zhang, Yang Xu, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Yanming Zhang, De-Pei Wu, Ying Wang
Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Man Huang, Tao Tao, Chao-Ling Wan, Tian-Mei Wu, Han-Yu Cao, Yan Qiu, Xiang-Dong Shen, Bin-Ru Wang, Shuai-Shuai Ge, Yan-Yan Li, Tong-Tong Zhang, Bing Wu, Sheng-Li Xue
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome-positive acute myeloid leukemia: A case report. Clinical case reports 11 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Shuai-Shuai Ge, Qiao-Cheng Qiu, Hai-Ping Dai, Xiang-Dong Shen, Tian-Mei Wu, Jia-Hui Du, Chao-Ling Wan, Hong-Jie Shen, De-Pei Wu, Sheng-Li Xue, Song-Bai Liu
Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy. British journal of haematology (2023)
Li Huo, Zhibo Zhang, Haixia Zhou, Jundan Xie, Airui Jiang, Qian Wang, Zixuan Ding, Hai-Ping Dai, Dandan Liu, Ni Wu, Qiaocheng Qiu, Liang Ma, Man Wang, Wenjuan Wang, Sheng-Li Xue, Zixing Chen, De-Pei Wu, Hong Yao, Suning Chen, Hongjie Shen
Causative germline variant p.Y259C of DDX41 recurrently identified in acute lymphoblastic leukaemia. British journal of haematology (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Fei Zhou, Tingting Pan, Xiaoli Li, Feng Du, Xiao Ma, Yanming Zhang, Depei Wu, Yue Han, Sheng-Li Xue, Miao Miao, Tao Tao, Xuefeng He, Suning Chen
Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276). Bone marrow transplantation (2023)
Si-Man Huang, Chao-Ling Wan, Han-Yu Cao, Yan-Yan Li, Chong-Sheng Qian, Hai-Xia Zhou, Ming-Zhu Xu, Xiao-Hui Hu, Lan Dai, Hai-Ping Dai, Sheng-Li Xue
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapy. Clinical case reports 11 (12) (2023)
Si-Man Huang, Tao Tao, Chao-Ling Wan, Tian-Mei Wu, Han-Yu Cao, Yan Qiu, Xiang-Dong Shen, Bin-Ru Wang, Shuai-Shuai Ge, Yan-Yan Li, Tong-Tong Zhang, Bing Wu, Sheng-Li Xue
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome-positive acute myeloid leukemia: A case report. Clinical case reports 11 (1) (2023)
Si-Ning Liu, Xin-Yue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Sheng-Li Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, De-Pei Wu, Qingya Cui, Xiao-Wen Tang
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal 13 (1) (2023)
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal 13 (1) (2023)
Yifan Zhai, Qiuqiong Tang, Douglas D Fang, Jing Deng, Kaixiang Zhang, Qixin Wang, Yan Yin, Chengcheng Fu, Sheng-Li Xue, Na Li, Feng Zhou, Dajun Yang
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Qian Wang, Wen-Zhi Cai, Qin-Rong Wang, Ming-Qing Zhu, Ling-Zhi Yan, Yan Yu, Xie-Bing Bao, Hong-Jie Shen, Hong Yao, Jun-Dan Xie, Tong-Tong Zhang, Ling Zhang, Xiao-Yu Xu, Zhe Shan, Hong Liu, Jian-Nong Cen, Dan-Dan Liu, Jin-Lan Pan, Da-Ru Lu, Jia Chen, Yang Xu, Ri Zhang, Ying Wang, Sheng-Li Xue, Miao Miao, Yue Han, Xiao-Wen Tang, Hui-Ying Qiu, Ai-Ning Sun, Jin-Yan Huang, Hai-Ping Dai, De-Pei Wu, Su-Ning Chen
Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia. American journal of hematology (2022)
Zhenzhen Yao, Bin Gu, Yanming Zhang, Jiaqian Qi, Jia Chen, Yang Xu, Feng Chen, Xiao Ma, Miao Miao, Sheng-Li Xue, Huiying Qiu, Xiao-Wen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, De-Pei Wu, Ying Wang
CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone marrow transplantation (2022)
Han-Yu Cao, Chao-Ling Wan, Sheng-Li Xue
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis. Annals of hematology (2022)
Lei-Si Zhang, Jun Wang, Ming-Zhu Xu, Tian-Mei Wu, Si-Man Huang, Han-Yu Cao, Ai-Ning Sun, Song-Bai Liu, Sheng-Li Xue
Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine. OncoTargets and therapy 15 (2022)
Li-Ling Zong, Xiang Zhang, Shan-Shan Jiang, Bo Hu, Yong-Qin Ge, Xia-Ming Zhu, Sheng-Li Xue, Jing Yang
Abnormal body composition related to the early clinical adverse outcome after HSCT. Bone marrow transplantation 57 (7) (2022)
Chong-Sheng Qian, Xiao Ma, Jin Wang, Ting-Jing Wang, Lian Bai, Hai-Xia Zhou, Ming-Zhu Xu, Ai-Ning Sun, De-Pei Wu, Song-Bai Liu, Sheng-Li Xue
PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation. Bone marrow transplantation 56 (5) (2020)

Sheng-Li Xue.css-eqlu8i{font-size:small;padding-left:4px;} (Shengli Xue)

Publication Activity (10 Years)

Top Topics

Top Venues

Sheng-Li Xue (Shengli Xue)